IL6 and breast carcinoma: IL-6 is a critical cytokine having a diverse actions on tumour development, invasion, chemoresistance and cancer stem cell formation.9,27,28 In this study, we reported that activated IL-6/IL-6R signalling suppressed the MAO-A activity in hypoxic breast cancer.